CTOs on the Move

Healthcare Interactive

www.hciactive.com

 
Healthcare Interactive, Inc. (HCIactive) is dedicated to revolutionizing the administration and delivery of healthcare. Through our patented, integrative technology and supplemental ancillary services, we afford clients the freedom, control and energy to provide high-performance plan solutions that mitigate risk and improve member outcomes. Disparate plan functions, such as enrollment and eligibility, incentive management and population health are seamlessly conducted through our single-source, cloud-based platform. The outcome: greater operational efficiency, actionable performance data, increased member participation, and overall reduced healthcare costs. Founded in 2006, HCIactive is the progressive leader in delivering integrated, health plan solutions to TPA`s, brokers, health systems, providers and their ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.hciactive.com
  • 3060 Route 97 Suite 200
    Glenwood, MD USA 21738
  • Phone: 866.397.9731

Executives

Name Title Contact Details

Similar Companies

Paradigm Capital

Paradigm Capital Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Salick Health Care

Salick Health Care is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Happify Health

Happify Health designs and deploys highly engaging software that can improve mental health, physical health, and well-being across the continuum of care. And we bring all sides of healthcare together, in partnership with leading enterprises, pharma, health plans, and healthcare clients around the world.

Unbound Medicine, Inc.

Unbound Medicine, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Media, VA. To find more information about Unbound Medicine, Inc., please visit www.unboundmedicine.com

Bioatla

BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.